AI Products 

Global Endobronchial Ultrasound Biopsy Market Size is Estimated to Witness High Growth Owing to Opportunity for Minimally Invasive Diagnosis

Gauri Cmi
Global Endobronchial Ultrasound Biopsy Market Size is Estimated to Witness High Growth Owing to Opportunity for Minimally Invasive Diagnosis

Endobronchial ultrasound biopsy (EBUS) is a minimally invasive procedure that enables real-time viewing of airways and lymph nodes inside the lung to help diagnose cancer or other diseases. EBUS systems integrate ultrasound technology with bronchoscopy to provide high quality images of lungs and detect abnormalities inside soft tissue and lymph nodes. The procedure is well-tolerated and allows collection of sample tissues for laboratory analysis without major surgery.


The global Endobronchial Ultrasound Biopsy Market is estimated to be valued at US$ 722.67 Bn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

Opportunity for Minimally Invasive Diagnosis

EBUS provides an opportunity for minimally invasive diagnosis of lung cancer and aids in staging of tumors without invasive surgery. It helps in guiding biopsy needles to diagnose cancer and also helps in detecting the spread of cancer to lymph nodes. This minimally invasive technique enables real-time imaging of the lungs and surrounding tissues to safely obtain tissue samples. With its advantages of being well-tolerated, outpatient procedure and providing accurate diagnosis, EBUS offers significant potential to become the standard of care for diagnosis and staging of lung cancers. Its demand is expected to increase further owing to growing prevalence of lung cancer worldwide.

Porter's Analysis

Threat of new entrants: Low due to high capital requirements and established brand loyalty of existing players in the Endobronchial Ultrasound Biopsy market. Bargaining power of buyers: Moderate as some key players dominate the market. Bargaining power of suppliers: Moderate due to availability of substitute products. Threat of new substitutes: Low as Endobronchial Ultrasound Biopsy has few close substitute products. Competitive rivalry: High among the key established players to increase their market share in the growing Endobronchial Ultrasound Biopsy market.

SWOT Analysis

Strength: Rising prevalence of lung cancer and improved diagnosis. Weakness: High procedural cost of Endobronchial Ultrasound Biopsy and skilled specialist requirement. Opportunity: Growth opportunities in developing regions. Threats: Stringent regulations for new product approvals and reimbursement issues.

Key Takeaways

Global Endobronchial Ultrasound Biopsy Market Size is expected to witness high growth during the forecast period of 2023 to 2030.

Key regional markets include North America, Europe, Asia Pacific, and Rest of the World. North America is expected to dominate the global market during the forecast period. This is attributed to factors such as rising prevalence of target diseases, growing aging population, developed healthcare infrastructure, favorable reimbursement policies, and presence of key players in the region.

Key players operating in the Endobronchial Ultrasound Biopsy market are Alf Engineering, F-TECH, Magna International, Metalsa, Nissin Kogyo, Sango Co., Ltd., Tata Precision Tubes, Tenneco, Thyssenkrupp AG, Vari-Form, and Yorozu. Key players are focused on expanding their geographic presence and addressing the growing demand through strategic partnerships and collaborations.


Get More Insights On This Topic: https://www.newsanalyticspro.com/global-endobronchial-ultrasound-biopsy-market-trends/

Gauri Cmi
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more